Keensight Capital
Keensight Capital is a European Growth Buyout private equity firm investing exclusively in profitable mid-market Technology and Healthcare companies via €10-800m tickets, supported by an in-house operating team and a proprietary portfolio community platform.
- Company typePrivate
- Founded2000
- HeadquartersParis, France
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Keensight Capital does
Keensight Capital is a European Growth Buyout private equity firm specialising exclusively in profitable, fast-growing mid-market Technology and Healthcare companies. Headquartered in Paris and regulated by the Autorité des Marchés Financiers (agreement GP-08000040), the firm deploys €10-800m tickets in minority or majority positions, with or without leverage, into companies generating €10-400m in revenues. Keensight invests across Europe with additional operating presence in London, Boston and Singapore, and reports reach across more than 90 countries. The firm originated as R Capital Management, the growth-investment arm of the Rothschild Group, before becoming independent under its Managing Partners.
Keensight operates two proprietary assets that distinguish it from a capital-only sponsor. Keensight Connect is an online collaborative platform that connects Founders, CEOs and senior executives of portfolio companies through functional communities (Finance, HR, Sales, Product, Marketing) for knowledge sharing and access to curated documentation. Keensight Performance is an in-house operating team of approximately 40 professionals providing embedded functional expertise across product, technology, marketing, AI, sales, capital markets and M&A throughout the investment lifecycle. As of December 31, 2025 the firm reports €8bn+ in assets under management, 88 cumulative investments, 51 exits, 39% IRR from exited investments, and 18% average annual portfolio revenue growth over the past five years.
Keensight generates revenue through private equity fund management fees on assets under management and carried interest on successful exits. Capital is sourced from institutional Limited Partners via its Investor Relations team and deployed via direct deal-sourcing relationships with founders, management teams and selling shareholders. The firm is independent and partner-owned (simplified joint-stock company, RCS Paris 509 104 527), led by Founding Partner Jean-Michel BEGHIN with senior leadership spanning Partner/COO Arnaud COHEN, CFO Adrien VAN EYNDE, Global Head of Investor Relations Charles COX, Head of ESG & Sustainability Ana ALVAREZ GRULLON and Head of Keensight Performance Stephane Prats. The current portfolio spans vertical software (Decision Focus, Aconso, SoftCo, Onventis, Quanos, Dimo Maint, ACTICO), IT services (Plat4mation, Valiantys, Nomios, Inherent), and Healthcare (Symeres, Inke, Bedfont Scientific, Isto Biologics, 3PBIOVIAN, Bentley, Unither, AXXAM, CatSci).
Keensight Capital firmographics
Firmographics- Name
- Keensight Capital
- Legal name
- Keensight Capital (société par actions simplifiée)
- Website
- https://keensight.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Keensight Capital is a European Growth Buyout private equity firm investing exclusively in profitable mid-market Technology and Healthcare companies via €10-800m tickets, supported by an in-house operating team and a proprietary portfolio community platform.
- Ownership category
- akta.pro rank
Keensight Capital industry classification
Industry- Product category
- Private Equity / Growth Buyout Investing
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Keensight Capital is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices4 records
Markets served
Keensight Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Private equity fund management fees & carried interest: Keensight Capital earns revenue by managing private equity funds and investing in profitable European Technology and Healthcare companies. Revenue is generated through management fees on assets under management and carried interest on successful exits. Keensight operates across more than 90 countries with €8bn+ AUM as of December 31, 2025.
- Fund capital deployment gains: Capital is invested via Growth Buyout structures (minority or majority, with or without leverage) in profitable companies generating €10-400m in revenues. Keensight reports a 39% IRR from 51 exited investments and 18% average annual portfolio revenue growth over the past 5 years, driving fund returns.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Investment ticket size range: €10m–€800m for portfolio companies generating €10m–€400m in revenues |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Keensight Capital product offering
Product offeringCore offering
Keensight Capital is a European Growth Buyout investor that deploys €10–800m tickets in minority or majority positions into profitable, fast-growing European Technology and Healthcare companies generating €10–400m in revenues. The firm provides capital alongside strategic guidance and operational support delivered through its proprietary Keensight Performance team of ~40 in-house professionals, while Keensight Connect serves as the online community platform for portfolio company executives.
Product overview
Keensight Capital is a European Growth Buyout investor (private equity firm) whose direct product offering is built around two proprietary assets: (1) Keensight Connect, an online collaborative platform serving as a community of communities for CEOs, founders and senior executives across Keensight's portfolio companies with curated best-practice documentation and live groups across Finance, HR, Sales, Product, and Marketing; and (2) Keensight Performance, an in-house operational support team of ~40 professionals providing on-demand expertise across product, technology, marketing, AI, sales, capital markets, M&A and revenue generation. Beyond these internal platforms, Keensight's broader commercial offering is its pan-European Growth Buyout investment service — providing €10–800m tickets in minority or majority positions to profitable Technology and Healthcare companies generating €10m–€400m in revenues. The investment vehicle is delivered through a portfolio of named operating companies, each with its own product: in Technology this includes Bedfont Scientific (non-invasive breath analysis medical devices), Decision Focus (no-code GRC SaaS with AI-powered capabilities), Isto Biologics (orthobiologics/regenerative MedTech), UVE (Route-to-Market analytics SaaS for CPG brands), Dimo Maint (CMMS SaaS), aconso (AI-powered HR document management), SoftCo (Procure-to-Pay SaaS), Plat4mation (ServiceNow Elite Partner services), MetaCompliance (Human Risk Management platform), Advancis (Physical Security Information Management), Nomios (cybersecurity services), ACTICO (regulatory compliance/risk management SaaS), Inherent (B2B cloud and connectivity services), Valiantys (Atlassian services), Onventis (cloud procurement), Sogelink (civil engineering digitalization), and Quanos (industrial aftersales documentation); in Healthcare, Symeres (drug discovery CRO/CDMO) and Inke (inhalation API manufacturing).
Differentiator
Problem solved
Functional benefit
Brands
- Keensight Connect: Online collaborative platform for Founders, CEOs and managers of Keensight's portfolio companies, designed as a community of communities for knowledge sharing across the portfolio.
- Keensight Performance
Products and services
- European Growth Buyout investment platform Core investment offering providing €10–800m investment tickets in minority or majority positions, with or without leverage, to fast-growing and profitable European Technology and Healthcare companies generating €10m to €400m in revenues. Includes tailor-made financing for organic growth, strategic acquisitions, or shareholder liquidity.
- Keensight Connect Online collaborative platform for Founders, CEOs and senior executives of Keensight's portfolio companies. It operates as a community of communities, connecting portfolio managers across multiple live groups (Finance, HR, Sales, Product, Marketing) and providing curated documentation and best-practice resources to support value creation.
- Keensight Performance In-house team of approximately 40 professionals providing on-demand operational support to portfolio companies, with in-house expertise across product, technology, marketing, AI, sales, capital markets, M&A, and revenue generation functions. Works alongside investment teams from the pre-deal phase through the investment lifecycle.
Quantifiable outcome
- 39% IRR from a total of 51 exited investments
- +6 more outcomes
Companies that use Keensight Capital
Customer profileNamed customers32 records
Segments5 records
Ideal customer profiles3 records
Keensight Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature2 records
Keensight Capital partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- ServiceNow Ecosystem VenturescoreServiceNow Ecosystem Ventures co-invests with Keensight Capital in Plat4mation to support the ServiceNow Elite Partner's international expansion. The recent Adeno acquisition (June 2026) is supported by both Keensight Capital and ServiceNow Ecosystem Ventures.
- CuatrecasasminorCuatrecasas advised UVE Solutions on the sale of a majority stake to Keensight Capital (December 2025). Keensight aims to accelerate UVE's international expansion and support new artificial intelligence investments.
- investorsinhealthcare (publisher reference)minorNews coverage of Keensight's majority stake acquisition in Bedfont Scientific.
- Advancis Software & Services GmbHcoreAdvancis Software & Services GmbH, a German provider of integrated physical security software, entered into a strategic partnership with French private equity firm Keensight Capital to accelerate its international growth and PSIM solution development (November 2024).
- ABN AMROcoreBuckaroo (Keensight's portfolio company) became the exclusive strategic partner of ABN AMRO for payment services in February 2024. This partnership leverages Keensight's portfolio to provide exclusive payment services to ABN AMRO.
- CVC Capital PartnerscoreKeensight Capital and CVC Capital Partners agreed to jointly lead Sogelink through its next phase of growth in November 2023. CVC also co-invested alongside Keensight in subsequent Sogelink acquisitions including Netisys (October 2024).
- Paul Hastings (Europe) LLPminorPaul Hastings advised Keensight Capital on its LBO acquisition of Valiantys (2022) and on Keensight's acquisition of a majority stake in Bedfont Scientific, a UK-based medical device company specializing in non-invasive breath analysis technology (October 2025). Repeated legal advisor relationship.
- William BlairminorWilliam Blair acted as the exclusive financial advisor to Valiantys in its pending sale to Keensight Capital (signed April 8, 2022).
Scale indicators13 records
Recent moves15 records
Expansion highlights6 records
Keensight Capital competitors and assessment
Company assessmentDirect peers
- Ardian: Large European private investment house with growth, buyout and secondaries strategies; comparable scale (€160bn+ AUM) and pan-European origination model make it a direct comparable for Keensight's growth buyout franchise.
- Eurazeo: Paris-headquartered listed private equity firm with European mid-market buyout activities; same French origin, similar mid-large ticket sizes and European focus make it the closest domestic peer to Keensight.
- Tikehau Capital: Paris-based alternative asset manager with private equity, private debt, real estate and capital markets strategies; comparable French origin, pan-European footprint and growth/buyout orientation.
- Bridgepoint: European mid-market private equity firm focused on profitable growth companies; similar ticket size range, pan-European deal sourcing and growth-buyout model make Bridgepoint a direct comparable.
- PAI Partners: Paris-based European private equity firm with growth-buyout focus across multiple sectors; comparable ticket sizes, French/European headquarters and mid-market growth orientation align closely with Keensight's positioning.
- Hg: London-based private equity firm exclusively focused on European software and technology-enabled services; similar sector specialization, mid-market ticket sizes and value-creation orientation make Hg the closest pure-technology comparable to Keensight's tech portfolio.
- Astorg: Paris-headquartered European private equity firm focused on mid-market buyouts in technology, healthcare and business services; closely comparable in French origin, sector focus and growth-buyout approach.
Broad incumbents
- CVC Capital Partners: Global private equity firm and existing Keensight co-investor (Sogelink); larger AUM and broader sector mandate make it an incumbent comparable rather than a direct peer, but the partnership dynamic is material to Keensight's deal flow.
- EQT Partners: Global private equity firm with strong European technology and healthcare franchises (EQT Growth, EQT Healthcare); much larger scale and broader strategy, but directly comparable in sector focus and European mid-large growth-buyout activity.
- BC Partners: European-headquartered global private equity firm executing mid-to-large buyouts; overlapping European deal flow and growth-buyout orientation, though at a larger average ticket size than Keensight.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Keensight Capital social profiles
Digital presenceKeensight Capital compliance and trust
Trust signalCompliance5 records
Keensight Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Keensight Capital leadership team
Management profileNumber of profiles
Profiles22 records
Keensight Capital subsidiaries and ownership
Company hierarchySubsidiaries34 records
Keensight Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Keensight Capital M&A and investment
M&A and investmentM&A28 records
Investments31 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Keensight Capital
What does Keensight Capital do?
Keensight Capital is a European Growth Buyout investor that deploys €10–800m tickets in minority or majority positions into profitable, fast-growing European Technology and Healthcare companies generating €10–400m in revenues. The firm provides capital alongside strategic guidance and operational support delivered through its proprietary Keensight Performance team of ~40 in-house professionals, while Keensight Connect serves as the online community platform for portfolio company executives.
Is Keensight Capital a public or private company?
Keensight Capital is a private company. It is classified as management employee owned and is currently operating.
When was Keensight Capital founded?
Keensight Capital was founded in 2000. It employs 101 to 250 people.
Where is Keensight Capital based?
Keensight Capital is headquartered in Paris, France, in the Europe region.
How does Keensight Capital make money?
Two revenue lines are on record. Private equity fund management fees & carried interest is the primary driver. The others are fund capital deployment gains.
Who are Keensight Capital's main competitors?
Direct peers on record are Ardian, Eurazeo, Tikehau Capital, Bridgepoint, PAI Partners, Hg and Astorg. Broad incumbents are CVC Capital Partners, EQT Partners and BC Partners.
Does Keensight Capital have an API?
No public API is recorded for Keensight Capital.
What industry is Keensight Capital in?
Keensight Capital's product category is Private Equity / Growth Buyout Investing. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.